Hubid, Baby Boy .
HRN: 26-76-07 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/28/2025
03/10/2025
PO
3.5ml
Q8h
AGE With Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes